Nanomedicine Viterbo 2016 – Second announcement

Dear colleague,
we are pleased to inform you about the progress in the organization of the fourth International Conference on Nanomedicine, entitled “NANOMEDICINE Viterbo 2016,” which will take place in the University of Tuscia (Viterbo, Italy) from Wednesday, September 21st, to Friday, September 23rd, 2016.

The list of invited speakers is completed and we are really satisfied about their high scientific level and enthusiasm for attending the conference!

Invited speakers:
Prof. Luigi Ambrosio
Prof. Sophia G. Antimisiaris
Prof. Yechezkel Barenholz
Prof. Paola Luciani
Prof. Dusica Maysinger
Prof. Francesco Ricci
Prof. Ester Segal
Prof. Gert Storm
Prof. Vladimir P. Torchilin
Prof. Thomas J. Webster

Abstract submission and Registration are now open!
Young researchers, post-docs and students are especially encouraged to attend and submit an abstract, focused on the central topics in the field of Nanomedicine:

• Diagnosis
• Therapy
• Theranostics
• Drug delivery
• Tissue engineering

Early bird registration – Important dates!
• Abstract submission deadline: May 15, 2016
You will be notified if your contribution has been accepted by May 30, 2016

• Your registration must be completed within June 15, 2016

Grants will be available for young researchers and four prizes will be awarded to the best poster presentations. Please visit the conference website, www.nanodrug.cnr.it, for detailed information.

We are looking forward to seeing you in Viterbo!
The Scientific Committee


loghi annuncioriprep

Surface Chemistry of Surfactants and Polymers
24-28 October 2016 in Lisbon, Portugal

Course Description

This five-day intensive course provides a comprehensive overview of the chemistry related to the behavior of surfactants and polymers in solution and at interfaces. All important aspects of surfactants and water soluble polymers, as well as combinations of the two, are covered during the course. Examples of topics are environmental and health aspects of surfactants, surfactant self-assembly, surfactant and polymer adsorption, mixed surfactant systems and surfactant-polymer systems in solution and at interfaces, polymers in solution, wetting, surface and interfacial tension, rheology, micro-emulsions, emulsions and foams, solid dispersions, colloidal stability, and the use of surfactants as templates for nanomaterials.

Surfactants and polymers are used in a wide range of application areas, including detergents, cosmetics, pharmaceuticals, food, and coatings. The surface and colloid chemistry that is taught and discussed on the course is to a large extent generic and applicable to many of the aspects of formulation science and technology in these areas. Reference to practical uses of surfactants and water soluble polymers will be made in the lectures. There will also be scheduled time for group discussions.

The course is of interest to scientists, engineers and project managers working in the above-mentioned, or related, areas. The applicants are required to have general academic qualifications in chemistry, but no particular formal education in surface chemistry is required. All lectures and notes will be in English.
The book, Surface Chemistry of Surfactants and Polymers, is included in the course fee.

This course is being offered for the 25th consecutive time and it has been updated continuously. In previous years the course has attracted participants from almost every European country, as well as from the USA, Mexico, Venezuela, Brazil, China and South Korea.

GO TO WEBPAGE

Download PDF to read more
REGISTRATION FORM

Do not forget to submit your abstract to the VII Conference on AFM for Life Sciences and Nanomedicine. The deadline for abstract submission has been extended until the 12th FEBRUARY!

VII Conference on AFM for Life Sciences and Nanomedicine

• Porto • Portugal • 11–15 April 2016

Building up on the success of the previous editions, this year’s event will bring closer specialists from cell biology and medical science to materials science and physics, to discuss the latest technological advances and applications of AFM in the field of BIOIMAGING, MECHANOBIOLOGY, HEALTH AND DISEASE, and NANOMEDICINE.

The Conference will be hosted by i3S/INEB (Instituto de Investigação e Inovação em Saúde/Instituto de Engenharia Biomédica) at the Auditorium of Biblioteca Municipal Almeida Garrett, during four days and preceded by an AFM Workshop.


Bruker Workshop & Training Day
, the AFM Workshop with hands-on training that will be held on 11th April 2016. This workshop will present the new advances in Atomic Force Microscopy for Life Sciences. For additional information and registration, click here:

More information and the programme can be found at AFM BioMed Conference

graphene_flagship_logo_blue

Welcome to a Workshop in Grenoble, 23th February 2016

Meet your future graphene collaborators at Graphene Connect – Biomedical Technologies. Listen to state-of-the-art research, industry representatives giving their view of graphene in biosensor and implant applications. Engage in group discussions and networking.

The afternoon of 23th February 2016 is devoted to biosensor applications, while the morning of 24th focus on implants.

The programme includes popular presentation (general overview) on state-of-the art research by the work package leaders presenting the plan for the coming years, industry perspectives by industry representatives and investors. Building on the presentations, there will be moderated group discussions with the possibility of representatives across industry sectors to interact with each other as well as with researchers. The aim is to strengthen collaboration throughout the value chain from researchers, to component, system producers and end-users.

REGISTRATION OPEN
Speakers
Kostas Kostarelos, University of Manchester
Lubomir Gradinarsky, Astra Zeneca
Daniel Chew, Glaxo Smith Kline
Clemens Boucsein, Multichannel Systems
Guillaume Buc, Pixium Vision
Francois Berger, Clinatec

Graphene Connect is an enabling instrument of the Graphene Flagship to engage in a direct dialogue and envision new collaborations between European companies and academics working in applied research, innovation and development related to graphene and other 2D materials.

Graphene Connect industry series provides an excellent opportunity to get an overview on research activities within the Graphene Flagship, as well as industry demands.

european_commission_logo Graphene Flagship Founded by the European Union

Call for Abstracts • Due December 11

The 18th Annual Nanotech 2016 Conference will be held May 22-25, Gaylord Convention Center, Washington DC, USA. Abstract submission for technical talks and posters are due Dec. 11th. On behalf of our symposium organizers we warmly invite you to submit your research abstract and participate in this exciting international event.

For Abstract Submission link to your Symposium of Interest below. For Exhibit Info link here.

Join leading technology and solution providers at the largest expo built specifically for the global innovation community.

TechConnect World, co-located with the National SBIR Conference and the National Innovation Summit, delivers the world’s largest gathering of commercialization-focused innovators from Federal Agencies, Federal & Academic Labs, Corporate Tech Developers, and Start-up & SBIR Companies.

The joint events, delivers over 4,000 attendees from over
 70 countries supporting the development and commercialization of new innovations. As an exhibitor, you will access the corporate executives, researchers, engineers, federal funders and commercialization leadership that rely on your products and services to develop these new technologies.
Access over $20 Billion in Federal Programs, Facilities, Global 1000s & Start-Ups

Exhibit at the TechConnect World Expo and showcase your company’s products and services to the largest gathering of federal funding agencies, research laboratories, corporate technology developers and start-up companies world-wide.
For more information, including a detailed prospectus & floor plan, please contact Denise Lee at (email) or +1 203.421.6347.

1st announcement an call for papers!

Download PDF
CLINAM 9 / 2016 Conference and Exhibition
European & Global Summit for Cutting-Edge Medicine
June 26 – 29, 2016 • Basel, Switzerland

The Conference at a Glance

In the previous eight years, the CLINAM Summit grew to the largest in its field with 12 presenting Noble Laureates and more than 500 participants from academia, industry, regulatory authorities and policy from over 40 different countries in Europe and worldwide. With this success and broad support by well beyond 20 renowned collaborating initiatives, the CLINAM-Summit is today one of the most important marketplaces for scientific exchange and discussions of regulatory, political and ethical aspects in this field of cutting edge medicine.

In particular, the CLINAM Summit emerged as exquisite forum for translation from bench to bedside, for European and international networking, and for industrial collaboration between companies, with academia, and point-of-contact with customers. The summit is presently the only place to meet the regulatory authorities from all continents to debate the needs of all stakeholders in the field with the legislators.

CLINAM 9/2016 continues with its successful tradition to cover the manifold interdisciplinary fields of Clinical and Targeted Nanomedicine in major and neglected diseases. As special focus area, CLINAM 09/2016 adds translation and enabling technologies, including, for example, cutting-edge molecular profiling, nano-scale analytics, single cell analysis, stem cell technologies, tissue engineering, in and ex vivo systems as well as in vitro substitute systems for efficacy and toxicity testing.

CLINAM 09/2016 covers the entire interdisciplinary spectrum of Nanomedicine and Targeted Medicine from new materials with potential medical applications and enabling technologies over diagnostic and therapeutic translation to clinical applications in infectious, inflammatory and neurodegenerative diseases, as well as diabetes, cancer and regenerative medicine to societal implications, strategical issues, and regulatory affairs. The conference is sub-divided into four different tracks running in parallel and provides ample possibilities for exhibitors as indicated by steadily increasing requests:

The Tracks and Topics of the Conference

TRACK 1: Clinical and Targeted Nanomedicine – Basic Research • Disease Mechanisms and Personalized Medicine • Regenerative Medicine • Novel Therapeutic and Diagnostic Approaches • Active and Passive Targeting • Targeted Delivery (antibodies, affibodies, aptamers, nano drug delivery devices) • Accurin Technology •Nano-Toxicology

TRACK 2: Clinical and Targeted Nanomedicine: Translation • Unsolved Medical Problems• Personalized Medicine and Theranostic Approaches • Regenerative Medicine • Advanced Breaking and Ongoing Clinical Trials • Applied Nanomedical Diagnostics and Therapeutics

TRACK 3: Enabling Technologies• Nanomaterial Analytics and Testing • Molecular Profiling for Research and Efficacy/Toxicology Testing (Genomics, Proteomics, Glycomics, Lipidomics, Metabolomics) • Functional Testing Assays and Platforms• Single Cell Analyses • Cell Tracking • Stem Cell Biology and Engineering Technologies • Microfluidics • Tissue Engineering – Tissues-on-a-Chip – Bioprinting •In vivo Testing •Novel Imaging Approaches • Medical Devices Track 4: Regulatory, Societal Affairs and Networking • Regulatory Issues in Nanomedicine • Strategy and Policy • The Patients` Perspective • Ethical Issues in Nanomedicine • University Village • Cutting-Edge EU-Project Presentations • Networking for International Consortium Formation

BioNanoMed 2016, call for papers

7th International Congress BioNanoMed 2016 – Nanotechnology enables Personalized  Medicine which will be held on 6 – 8 April 2016 at the Danube University in Krems / Austria.

CALL FOR PAPERS!
In addition to prominent invited speakers a limited number of talks and poster presentations can be accepted. You are cordially invited to submit your abstract!

SCIENTIFIC PROGRAM

Topics

• Nanomaterials for Biomedical Applications
• Regenerative Nanomedicine – Nanotechnology and Stem Cells
•  Nanotechnology for Detection, Diagnosis, Imaging & Sensing
• NanoPharmaceuticals & Drug Design
• Nano Oncology: Drug Delivery & Therapeutics

Thematic Sessions

I –  3D-Technologies for Nanomedicine
II – Nanomaterials Toxicology & NanoSafety Aspects
(co-organized by EURO-NanoTox

POSTER AWARDS
Danube University Poster Awards 2015 are granted to the three best poster contributions (€ 400 for the first, € 300 for the second and € 200 for the third place)

EXHIBITION & SPONSORING
BioNanoMed 2016 serves as an excellent platform to present your company/institution, to promote your product portfolio and to establish direct links to a broad audience of experts. By becoming an exhibitor or sponsor you will make a great contribution to support the BioNanoMed 2016 congress.

IMPORTANT DATES
Deadline for oral abstracts: 8 January 2016
Deadline for poster abstracts: 11 March 2016
End of early registration: 8 February 2016
End of online registration: 1 April 2016

If you require further information do not hesitate to contact our conference office at office@bionanomed.at <mailto:office@bionanomed.at> .

We are looking forward to your contribution!

Kind regards,
BioNanoMed 2016 Organizing Team

Dear colleagues, welcome to ENM2015 Meeting in Grenoble!

Ban_ENM_V2-reduitThe French Society for Nanomedicine, together with the british society for nanomedicine, the dutsch society for nanomedicine, the german nanomedicine platform, and the European Nanomedicine platform organise the Nanomed Europe meeting this year in France, december 7-9th.

The themes are surely of great interests for you:
• Nanomedicine and cancer
• Nanomedicines for imaging, as devices or for regenerative medicine
What nanomedicine can do for macromolecules delivery and toxicity issues will be part of the sessions.

Great speakers have accepted to join the conference, they are both coming from academia and private companies and will attend roundtable discussions:
Arwyn Jones, Muthiah Manoharan (Alnylam), Charlie Gosse, Bruno Le Pioufle, Andrew Owen, Peter Wick, Hisataka Kobayashi (USA), Eric Vibert, Elias Fatal, François Berger, Marianne Ahsford (Astra Zeneca), Nicolas Grenier, Twan Lammers, Pierre-Yves Benhamou, Pierre Nassoy

For more detailed informations, please check our website, click here

Obviously, all conferences will be in english !
Do not hesitate to transfer the informations to students and colleagues who might be interested and send your abstract before september 30th!

Apply for the Nanomedicine award 2015

The ETPN and the ENATRANS CSA have launched the second edition of the Nanomedicine Award to honour the best international nanomedicine innovations for 2015. The Award will be presented at the BIO-Europe conference in Munich in November 2015.

We strongly encourage to apply for the nanomedicine Awards 2015 by submitting their projects in both categories!

The application form is available online at nanomedicine-award.com

diamantThe goal of the Award is to promote and reward two excellent innovative nanomedicine-based solutions that could help physicians change the way diseases are treated and diagnosed, bringing significant benefits to patients.

The Award is open to companies as well as academic and private researchers across the globe. Nominated projects should be totally new diagnostic and therapeutic approaches that address unmet medical needs with nanomedicine, and have an explicit and defined potential market.

Nanomedicine proposals will be evaluated in two categories:
• Award for Best early clinical stage project
• Award for Best product or deal

Applications will be reviewed and assessed by a panel of highly-qualified industry experts with experience in R&D and business roles:
– Patrick Boisseau, Business Development Nanomedicine at CEA-Leti and President of the ETPN
– Patrick Tricoli, VP Corporate Development and CEO Nanobiotix Corp.
– Jeff Hrkach, formerly Chief Technology Officer of BIND Therapeutics, Inc. and member of the Nanomedicines Alliance
– Henry Havel, formerly Senior Research Fellow at Eli Lilly and Chairman of the Nanomedicines Alliance

The Award is supported by the EBD Group, the leading partnering firm for the global life science industry, the Nanomedicines Alliance, the US-based consortium dedicated to promoting and facilitating the scientific advancement, regulatory approval, and public appreciation of nanotechnology-based medicines and Nanobiotix, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer.

The Award ceremony will take place during BIO-Europe 2015 in Munich (Germany) on the 3rd November 2015.

Winners will benefit from a full registration (including partnering) for BIO-Europe 2015 and a 10 minutes project presentation during the Conference. The winning projects will also be granted with a presentation during the ETPN General Assembly 2016, along with 1 year’s free ETPN membership and a consulting action by the experts from the Translation Advisory Board (TAB). The winners will gain visibility to EU decision makers from pharma industry, academia, finance and media.

Applications for the Award are open until 15th September 2015.The application form is available online at nanomedicine-award.com

Contacts

ENATRANS Coordinator
Nicolas GOUZE
ETPN Secretariat c/o VDI/VDE-IT
Nicolas.gouze@vdivde-it.de
Tel.: +49 30 310078 209

ENATRANS Communication

Sarah GAUBERT
Violaine EMOURGEON
sarah.gaubert@nanobiotix.com
violaine.emourgeon@nanobiotix.com
Tel.: + 33 1 75 44 69 42
SAVE THE DATE!
ETPN Annual Event 2015
Dublin, October 12th -14th 2015

Do you have an ambitious nanobiomedicine project? Apply and benefit from high level experts support!

Skärmavbild 2015-08-03 kl. 11.19.07ENATRANS launches the first Translation Advisory Board (TAB), a new instrument to provide free of charge advice and support to ambitious international nanomedicine projects.

The call is open to companies, academics and private researchers in Europe promoting nanomedicine projects. First-in-class recognized experts from industry will deliver concrete and invaluable advice to drive selected nanomedicine projects into innovative products for healthcare. Among those ambitious projects, the most promising will benefit from further high value services such as in-depth advice, showcase and coaching…  (Download the Flyer)

The applicants must have very promising nanomedicine projects, targeting unmet medical need for patients.

Applications received till September 14, 2015 may be eligible for the first TAB-in session, which will gather selected projects in a first phase of the service to be organised in Dublin, October 14, 2015.

APPLY HERE
Who are the experts?

Paul Smit – former senior position at Philips Healthcare, Mike Eaton – former senior positions at Celltech & UCB, David Bott – former senior position at BP, Ruediger Iden – former senior position at BASF, Eckhard Schwenner – former position at Bayer, Eric Mayes – CEO at Endomag, Laurent Levy – CEO at Nanobiotix